Neutrophil Elastase and Chronic Lung Disease

Area of Science:

• Pulmonary Medicine
• Inflammation Research
• Biochemistry

Background:

• Neutrophil elastase (NE) is a key protease released by neutrophils.
• Elevated NE levels are found in airway diseases such as cystic fibrosis (CF), COPD, bronchiectasis, and bronchopulmonary dysplasia.
• While NE aids in infection control, its presence in the airways exacerbates chronic inflammation and tissue damage.

Purpose of the Study:

• To review the multifaceted role of NE in airway inflammation and remodeling.
• To discuss the mechanisms by which NE impairs epithelial repair and innate immunity.
• To highlight the limitations of current NE-directed therapies and the potential of novel therapeutic strategies.

Main Methods:

• Literature review of NE's function in chronic airway inflammatory diseases.
• Analysis of NE's impact on cellular processes including apoptosis, senescence, and mucin secretion.
• Examination of NE's effects on immune cell function and inflammatory mediator release.

Main Results:

• NE contributes to airway remodeling, increased mucus production, and reduced ciliary function.
• NE disrupts epithelial repair by inducing apoptosis and senescence.
• NE activates inflammation through direct cytokine release and indirect mechanisms involving extracellular traps and exosomes.
• NE impairs innate immunity by degrading key immune proteins and inhibiting phagocytosis.

Conclusions:

• Neutrophil elastase plays a significant detrimental role in the pathogenesis of various chronic airway diseases.
• Existing NE-targeting therapies have not successfully mitigated the pathological consequences of NE exposure.
• Emerging therapies aim to provide both direct protease inhibition and broad anti-inflammatory effects for improved clinical outcomes.